{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T02:09:23Z","timestamp":1778465363188,"version":"3.51.4"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA039299"],"award-info":[{"award-number":["K01DA039299"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"DOI":"10.1007\/s00213-026-07071-2","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:35:04Z","timestamp":1778459704000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroimaging as the \u2018missing link\u2019 for preclinical to clinical translation: an example using N-acetylcysteine among individuals with cocaine- and opioid-use disorders receiving methadone treatment"],"prefix":"10.1007","author":[{"given":"Spencer","family":"Birney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annie","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Babuscio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Dwy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skye","family":"Orazietti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick D.","family":"Worhunsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet","family":"Sofuoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Constable","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc N.","family":"Potenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2293-2864","authenticated-orcid":false,"given":"Sarah W.","family":"Yip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"3","key":"7071_CR53","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1369-1600.2012.00497.x","volume":"19","author":"N Albein-Urios","year":"2014","unstructured":"Albein-Urios N, Verdejo-Rom\u00e1n J, Asensio S, Soriano-Mas C, Mart\u00ednez-Gonz\u00e1lez JM, Verdejo-Garc\u00eda A (2014) Re-appraisal of negative emotions in cocaine dependence: dysfunctional corticolimbic activation and connectivity. Addict Biol 19(3):415\u2013426","journal-title":"Addict Biol"},{"key":"7071_CR75","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mentaldisorders: DSM-5. 5th edn. American Psychiatric Publishing","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"7","key":"7071_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nn1069","volume":"6","author":"DA Baker","year":"2003","unstructured":"Baker DA, McFarland K, Lake RW et al (2003) Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6(7):743\u2013749","journal-title":"Nat Neurosci"},{"issue":"6","key":"7071_CR41","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.biopsych.2008.04.022","volume":"64","author":"M Berk","year":"2008","unstructured":"Berk M, Copolov DL, Dean O et al (2008) N-acetyl cysteine for depressive symptoms in bipolar disorder\u2013a double-blind randomized placebo-controlled trial. Biol Psychiatry 64(6):468\u2013475","journal-title":"Biol Psychiatry"},{"issue":"1\u20133","key":"7071_CR43","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jad.2011.06.005","volume":"135","author":"M Berk","year":"2011","unstructured":"Berk M, Dean O, Cotton SM et al (2011) The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. J Affect Disord 135(1\u20133):389\u2013394","journal-title":"J Affect Disord"},{"issue":"6","key":"7071_CR42","doi-asserted-by":"publisher","first-page":"628","DOI":"10.4088\/JCP.13m08454","volume":"75","author":"M Berk","year":"2014","unstructured":"Berk M, Dean OM, Cotton SM et al (2014) The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 75(6):628\u2013636","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"7071_CR74","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40263-022-00907-3","volume":"36","author":"RCJ Bradlow","year":"2022","unstructured":"Bradlow RCJ, Berk M, Kalivas PW, Back SE, Kanaan RA (2022) The potential of N-Acetyl-L-Cysteine (NAC) in the treatment of psychiatric disorders. CNS Drugs 36(5):451\u2013482","journal-title":"CNS Drugs"},{"key":"7071_CR57","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/j.1360-0443.1996.tb03621.x","volume":"91","author":"C Breslin","year":"1996","unstructured":"Breslin C, Sobell LC, Sobell MB, Buchan G, Kwan E (1996) Aftercare telephone contacts with problem drinkers can serve a clinical and research function. Addiction 91:1359\u20131364","journal-title":"Addiction"},{"key":"7071_CR39","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3389\/fnbeh.2014.00219","volume":"8","author":"Y-W Chen","year":"2014","unstructured":"Chen Y-W, Lin H-C, Ng M-C et al (2014) Activation of mGluR2\/3 underlies the effects of N-acetylcystein on amygdala-associated autism-like phenotypes in a valproate-induced rat model of autism. Front Behav Neurosci 8:219","journal-title":"Front Behav Neurosci"},{"issue":"10","key":"7071_CR54","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1002\/hbm.22913","volume":"36","author":"CL Crunelle","year":"2015","unstructured":"Crunelle CL, Kaag AM, Van den Munkhof HE et al (2015) Dysfunctional amygdala activation and connectivity with the prefrontal cortex in current cocaine users. Hum Brain Mapp 36(10):4222\u20134230","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"7071_CR63","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1590\/2237-6089-2016-0043","volume":"39","author":"FR Czermainski","year":"2017","unstructured":"Czermainski FR, Willhelm AR, Santos \u00c1Z, Pachado MP, de Almeida RMM (2017) Assessment of inhibitory control in crack and\/or cocaine users: a systematic review. Trends in Psychiatry and Psychotherapy 39(3):216\u2013225","journal-title":"Trends in Psychiatry and Psychotherapy"},{"issue":"2","key":"7071_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","volume":"165","author":"L Dutra","year":"2008","unstructured":"Dutra L, Stathopoulou G, Basden S, Leyro T, Powers M, Otto M (2008) A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 165(2):179\u2013187","journal-title":"Am J Psychiatry"},{"key":"7071_CR36","doi-asserted-by":"publisher","first-page":"554613","DOI":"10.3389\/fncel.2020.554613","volume":"14","author":"C Fan","year":"2020","unstructured":"Fan C, Long Y, Wang L et al (2020) N-Acetylcysteine rescues hippocampal oxidative stress-induced neuronal injury via suppression of p38\/JNK signaling in depressed rats. Front Cell Neurosci 14:554613","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"7071_CR64","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.neubiorev.2010.03.001","volume":"35","author":"J Feil","year":"2010","unstructured":"Feil J, Sheppard D, Fitzgerald PB, Y\u00fccel M, Lubman DI, Bradshaw JL (2010) Addiction, compulsive drug seeking, and the role of frontostriatal mechanisms in regulating inhibitory control. Neurosci Biobehav Rev 35(2):248\u2013275","journal-title":"Neurosci Biobehav Rev"},{"key":"7071_CR35","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.bbr.2019.02.025","volume":"364","author":"J Fernandes","year":"2019","unstructured":"Fernandes J, Gupta GL (2019) N-acetylcysteine attenuates neuroinflammation associated depressive behavior induced by chronic unpredictable mild stress in rat. Behav Brain Res 364:356\u2013365","journal-title":"Behav Brain Res"},{"key":"7071_CR17","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.bbr.2014.02.044","volume":"266","author":"M Frankowska","year":"2014","unstructured":"Frankowska M, Jastrzebska J, Nowak E, Bialko M, Przegalinski E, Filip M (2014) The effects of N-acetylcysteine on cocaine reward and seeking behaviors in a rat model of depression. Behav Brain Res 266:108\u2013118","journal-title":"Behav Brain Res"},{"key":"7071_CR50","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1176\/appi.ajp.157.11.1789","volume":"157","author":"H Garavan","year":"2000","unstructured":"Garavan H, Pankiewicz J, Bloom A, Cho J-K, Sperry L, Ross TJ, Salmeron BJ, Risinger R, Kelley D, Stein EA (2000b) Cue-induced cocaine craving: Neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 157:1789\u20131798","journal-title":"Am J Psychiatry"},{"issue":"11","key":"7071_CR33","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1176\/appi.ajp.157.11.1789","volume":"157","author":"H Garavan","year":"2000","unstructured":"Garavan H, Pankiewicz J, Bloom A et al (2000a) Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry 157(11):1789\u20131798","journal-title":"Am J Psychiatry"},{"issue":"23","key":"7071_CR51","doi-asserted-by":"publisher","first-page":"9453","DOI":"10.1073\/pnas.0900491106","volume":"106","author":"RZ Goldstein","year":"2009","unstructured":"Goldstein RZ, Alia-Klein N, Tomasi D et al (2009) Anterior cingulate cortex hypoactivations to an emotionally salient task in cocaine addiction. Proc Natl Acad Sci U S A 106(23):9453\u20139458","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"7071_CR34","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1038\/nrn3119","volume":"12","author":"RZ Goldstein","year":"2011","unstructured":"Goldstein RZ, Volkow ND (2011) Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci 12(11):652\u2013669","journal-title":"Nat Rev Neurosci"},{"key":"7071_CR68","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.pnpbp.2015.10.007","volume":"65","author":"JE Grant","year":"2016","unstructured":"Grant JE, Odlaug BL, Chamberlain SR (2016) Neural and psychological underpinnings of gambling disorder: a review. Prog Neuropsychopharmacol Biol Psychiatry 65:188\u2013193","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"7071_CR65","first-page":"16833","volume":"74","author":"JE Grant","year":"2013","unstructured":"Grant JE, Odlaug BL, Chamberlain SR et al (2013) A randomized, placebo-controlled trial of N-acetylcysteine plus imaginal desensitization for nicotine-dependent pathological gamblers. J Clin Psychiatry 74(1):16833","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"7071_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s40473-022-00250-3","volume":"9","author":"NR Greenberg","year":"2022","unstructured":"Greenberg NR, Farhadi F, Kazer B, Potenza MN, Angarita GA (2022a) Mechanistic effects and use of N-acetylcysteine in substance use disorders. Curr Behav Neurosci Rep 9(4):124\u2013143","journal-title":"Curr Behav Neurosci Rep"},{"issue":"4","key":"7071_CR67","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1007\/s40429-022-00446-3","volume":"9","author":"NR Greenberg","year":"2022","unstructured":"Greenberg NR, Farhadi F, Kazer B, Potenza MN, Angarita GA (2022b) The potential of N-acetyl cysteine in behavioral addictions and related compulsive and impulsive behaviors and disorders: a scoping review. Curr Addict Rep 9(4):660\u2013670","journal-title":"Curr Addict Rep"},{"issue":"4","key":"7071_CR45","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/archpsyc.59.4.375","volume":"59","author":"D Hasin","year":"2002","unstructured":"Hasin D, Liu X, Nunes E, McCloud S, Samet S, Endicott J (2002) Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry 59(4):375\u2013380","journal-title":"Arch Gen Psychiatry"},{"key":"7071_CR9","first-page":"6","volume":"19","author":"C Hendershot","year":"2011","unstructured":"Hendershot C, Witkiewitz K, George W, Marlatt G (2011) Relapse prevention for addictive behaviors. Susbt Abuse Treat Prev Policy 19:6\u201317","journal-title":"Susbt Abuse Treat Prev Policy"},{"issue":"2","key":"7071_CR56","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2165\/00003088-199120020-00004","volume":"20","author":"MR Holdiness","year":"1991","unstructured":"Holdiness MR (1991) Clinical pharmacokinetics of N-acetylcysteine. Clin Pharmacokinet 20(2):123\u2013134","journal-title":"Clin Pharmacokinet"},{"key":"7071_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrn2515","volume":"10","author":"P Kalivas","year":"2009","unstructured":"Kalivas P (2009) The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10:561\u2013572","journal-title":"Nat Rev Neurosci"},{"key":"7071_CR26","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/mp.2011.46","volume":"16","author":"P Kalivas","year":"2011","unstructured":"Kalivas P, Volkow N (2011) New medications for drug addiction hiding in glutamatergic neuroplasticity. Mol Psychiatry 16:974\u2013986","journal-title":"Mol Psychiatry"},{"issue":"3","key":"7071_CR6","first-page":"393","volume":"100","author":"F Kamal","year":"2007","unstructured":"Kamal F, Flavin S, Campbell F, Behan C, Fagan J, Smyth R (2007) Factors affecting the outcome of methadone maintenance treatment in opiate dependence. Ir Med J 100(3):393\u2013397","journal-title":"Ir Med J"},{"issue":"6","key":"7071_CR60","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/cercor\/bhq216","volume":"21","author":"P Kanske","year":"2010","unstructured":"Kanske P, Heissler J, Sch\u00f6nfelder S, Bongers A, Wessa M (2010) How to regulate emotion? Neural networks for reappraisal and distraction. Cereb Cortex 21(6):1379\u20131388","journal-title":"Cereb Cortex"},{"issue":"6","key":"7071_CR46","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/cercor\/bhq216","volume":"21","author":"P Kanske","year":"2011","unstructured":"Kanske P, Heissler J, Schonfelder S, Bongers A, Wessa M (2011) How to regulate emotion? Neural networks for reappraisal and distraction. Cereb Cortex 21(6):1379\u20131388","journal-title":"Cereb Cortex"},{"key":"7071_CR48","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1038\/tp.2014.137","volume":"5","author":"P Kanske","year":"2015","unstructured":"Kanske P, Schonfelder S, Forneck J, Wessa M (2015) Impaired regulation of emotion: neural correlates of reappraisal and distraction in bipolar disorder and unaffected relatives. Transl Psychiatry 5:e497","journal-title":"Transl Psychiatry"},{"issue":"21","key":"7071_CR31","doi-asserted-by":"publisher","first-page":"7839","DOI":"10.1523\/JNEUROSCI.23-21-07839.2003","volume":"23","author":"JN Kaufman","year":"2003","unstructured":"Kaufman JN, Ross TJ, Stein EA, Garavan H (2003) Cingulate hypoactivity in cocaine users during a GO-NOGO task as revealed by event-related functional magnetic resonance imaging. J Neurosci 23(21):7839\u20137843","journal-title":"J Neurosci"},{"issue":"1","key":"7071_CR27","first-page":"79","volume":"728","author":"R Kawashima","year":"1996","unstructured":"Kawashima R, Satoh K, Itoh H et al (1996) Functional anatomy of GO\/NO-GO discrimination and response selection\u2013a PET study in man. Brain Res 728(1):79\u201389","journal-title":"Brain Res"},{"issue":"14","key":"7071_CR37","doi-asserted-by":"publisher","first-page":"5450","DOI":"10.7150\/ijbs.97723","volume":"20","author":"HB Kim","year":"2024","unstructured":"Kim HB, Kim YJ, Lee YJ et al (2024) N-Acetylcysteine alleviates depressive-like behaviors in adolescent EAAC1(-\/-) mice and early life stress model rats. Int J Biol Sci 20(14):5450\u20135473","journal-title":"Int J Biol Sci"},{"issue":"2","key":"7071_CR70","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/npp.2015.193","volume":"41","author":"H Kober","year":"2016","unstructured":"Kober H, Lacadie CM, Wexler BE, Malison RT, Sinha R, Potenza MN (2016) Brain activity during cocaine craving and gambling urges: an fMRI study. Neuropsychopharmacology 41(2):628\u2013637","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"7071_CR10","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1001\/archpsyc.1986.01800080019003","volume":"43","author":"TR Kosten","year":"1986","unstructured":"Kosten TR, Rounsaville BJ, Kleber HD (1986) A 2.5 year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry 43(8):733\u20138","journal-title":"Arch Gen Psychiatry"},{"issue":"11","key":"7071_CR16","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.biopsych.2011.10.024","volume":"71","author":"YM Kupchik","year":"2012","unstructured":"Kupchik YM, Moussawi K, Tang XC et al (2012) The effect of N-acetylcysteine in the nucleus accumbens on neurotransmission and relapse to cocaine. Biol Psychiatry 71(11):978\u2013986","journal-title":"Biol Psychiatry"},{"issue":"3","key":"7071_CR72","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1176\/appi.ajp.2007.07010070","volume":"165","author":"DD Langleben","year":"2008","unstructured":"Langleben DD, Ruparel K, Elman I et al (2008) Acute effect of methadone maintenance dose on brain fMRI response to heroin-related cues. Am J Psychiatry 165(3):390\u2013394","journal-title":"Am J Psychiatry"},{"issue":"7","key":"7071_CR19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1176\/ajp.2007.164.7.1115","volume":"164","author":"PDS LaRowe","year":"2007","unstructured":"LaRowe PDS, Myrick MDH, Hedden MSS et al (2007) Is cocaine desire reduced by N-Acetylcysteine? Am J Psychiatry 164(7):1115\u20131117","journal-title":"Am J Psychiatry"},{"issue":"5","key":"7071_CR20","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1521-0391.2013.12034.x","volume":"22","author":"SD LaRowe","year":"2013","unstructured":"LaRowe SD, Kalivas PW, Nicholas JS, Randall PK, Mardikian PN, Malcolm RJ (2013) A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. Am J Addict 22(5):443\u2013452","journal-title":"Am J Addict"},{"issue":"8","key":"7071_CR30","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1038\/sj.npp.1301568","volume":"33","author":"CSR Li","year":"2008","unstructured":"Li CSR, Huang C, Yan P, Bhagwagar Z, Milivojevic V, Sinha R (2008) Neural correlates of impulse control during stop signal inhibition in cocaine-dependent men. Neuropsychopharmacology 33(8):1798\u2013806","journal-title":"Neuropsychopharmacology"},{"issue":"51","key":"7071_CR14","doi-asserted-by":"publisher","first-page":"13968","DOI":"10.1523\/JNEUROSCI.2808-07.2007","volume":"27","author":"A Madayag","year":"2007","unstructured":"Madayag A, Lobner D, Kau KS et al (2007) Repeated N-acetylcysteine administration alters plasticity-dependent effects of cocaine. J Neurosci 27(51):13968\u201313976","journal-title":"J Neurosci"},{"issue":"2","key":"7071_CR18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.pnpbp.2006.10.001","volume":"31","author":"PN Mardikian","year":"2007","unstructured":"Mardikian PN, LaRowe SD, Hedden S, Kalivas PW, Malcolm RJ (2007) An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry 31(2):389\u2013394","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"7071_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40263-014-0142-x","volume":"28","author":"EA McClure","year":"2014","unstructured":"McClure EA, Gipson CD, Malcolm RJ, Kalivas PW, Gray KM (2014) Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs 28(2):95\u2013106","journal-title":"CNS Drugs"},{"key":"7071_CR52","doi-asserted-by":"crossref","unstructured":"Mchugh MJ, Demers CH, Salmeron BJ, Devous MD, Stein EA, Adinoff B (2014) Cortico-amygdala coupling as a marker of early relapse risk in cocaine-addicted individuals. Front Psychiatry 5:16","DOI":"10.3389\/fpsyt.2014.00016"},{"issue":"2","key":"7071_CR15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/j.1369-1600.2011.00330.x","volume":"17","author":"JE Murray","year":"2012","unstructured":"Murray JE, Everitt BJ, Belin D (2012) N-Acetylcysteine reduces early- and late-stage cocaine seeking without affecting cocaine taking in rats. Addict Biol 17(2):437\u2013440","journal-title":"Addict Biol"},{"key":"7071_CR1","unstructured":"NIDA (2024) Drug overdose deaths: facts and figures. Accessed 28 May 2025"},{"issue":"2","key":"7071_CR47","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.neuroimage.2004.06.030","volume":"23","author":"KN Ochsner","year":"2004","unstructured":"Ochsner KN, Ray RD, Cooper JC et al (2004) For better or for worse: neural systems supporting the cognitive down- and up-regulation of negative emotion. Neuroimage 23(2):483\u2013499","journal-title":"Neuroimage"},{"issue":"6","key":"7071_CR2","doi-asserted-by":"publisher","first-page":"984","DOI":"10.2105\/AJPH.91.6.984","volume":"91","author":"PT O'Driscoll","year":"2001","unstructured":"O\u2019Driscoll PT, McGough J, Hagan H, Thiede H, Critchlow C, Alexander ER (2001) Predictors of accidental fatal drug overdose among a cohort of injection drug users. Am J Public Health 91(6):984\u2013987","journal-title":"Am J Public Health"},{"issue":"1507","key":"7071_CR69","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1098\/rstb.2008.0100","volume":"363","author":"MN Potenza","year":"2008","unstructured":"Potenza MN (2008) The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc B: Biol Sci 363(1507):3181\u20133189","journal-title":"Philos Trans R Soc B: Biol Sci"},{"issue":"1","key":"7071_CR66","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41572-019-0099-7","volume":"5","author":"MN Potenza","year":"2019","unstructured":"Potenza MN, Balodis IM, Derevensky J et al (2019) Gambling disorder. Nat Rev Dis Prim 5(1):51","journal-title":"Nat Rev Dis Prim"},{"issue":"13","key":"7071_CR32","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1038\/npp.2015.150","volume":"40","author":"S Ray","year":"2015","unstructured":"Ray S, Haney M, Hanson C, Biswal B, Hanson SJ (2015) Modeling causal relationship between brain regions within the drug-cue processing network in chronic cocaine smokers. Neuropsychopharmacology 40(13):2960\u20132968","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"7071_CR73","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1360-0443.2011.03634.x","volume":"107","author":"SM Savvas","year":"2012","unstructured":"Savvas SM, Somogyi AA, White JM (2012) The effect of methadone on emotional reactivity. Addiction 107(2):388\u2013392","journal-title":"Addiction"},{"issue":"9","key":"7071_CR24","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1038\/npp.2012.66","volume":"37","author":"L Schmaal","year":"2012","unstructured":"Schmaal L, Veltman DJ, Nederveen A, van den Brink W, Goudriaan AE (2012) N-acetylcysteine normalizes glutamate levels in cocaine-dependent patients: a randomized crossover magnetic resonance spectroscopy study. Neuropsychopharmacol 37(9):2143\u20132152","journal-title":"Neuropsychopharmacol"},{"issue":"2","key":"7071_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0376-8716(99)00157-X","volume":"60","author":"JM Schmitz","year":"2000","unstructured":"Schmitz JM, Stotts AL, Averill PM et al (2000) Cocaine dependence with and without comorbid depression: a comparison of patient characteristics. Drug Alcohol Depend 60(2):189\u2013198","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"7071_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1176\/appi.ajp.162.2.340","volume":"162","author":"RS Schottenfeld","year":"2005","unstructured":"Schottenfeld RS, Chawarski MC, Pakes JR, Pantalon MV, Carroll KM, Kosten TR (2005) Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence. Am J Psychiatry 162(2):340\u2013349","journal-title":"Am J Psychiatry"},{"issue":"6","key":"7071_CR5","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/j.1465-3362.2009.00064.x","volume":"28","author":"R Senbanjo","year":"2009","unstructured":"Senbanjo R, Wolff K, Marshall EJ, Strang J (2009) Persistence of heroin use despite methadone treatment: poor coping self-efficacy predicts continued heroin use. Drug Alcohol Rev 28(6):608\u2013615","journal-title":"Drug Alcohol Rev"},{"key":"7071_CR21","doi-asserted-by":"publisher","first-page":"107283","DOI":"10.1016\/j.addbeh.2022.107283","volume":"129","author":"R Sharma","year":"2022","unstructured":"Sharma R, Tikka SK, Bhute AR, Bastia BK (2022) N-acetyl cysteine in the treatment of cannabis use disorder: a systematic review of clinical trials. Addict Behav 129:107283","journal-title":"Addict Behav"},{"key":"7071_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.neuropharm.2012.06.021","volume":"64","author":"M Sofuoglu","year":"2013","unstructured":"Sofuoglu M, DeVito EE, Waters AJ, Carroll KM (2013) Cognitive enhancement as a treatment for drug addictions. Neuropharmacol 64:452\u2013463","journal-title":"Neuropharmacol"},{"key":"7071_CR29","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bbr.2013.06.001","volume":"256","author":"VR Steele","year":"2013","unstructured":"Steele VR, Aharoni E, Munro GE et al (2013) A large scale (N= 102) functional neuroimaging study of response inhibition in a Go\/NoGo task. Behav Brain Res 256:529\u2013536","journal-title":"Behav Brain Res"},{"key":"7071_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbr.2014.04.001","volume":"268","author":"VR Steele","year":"2014","unstructured":"Steele VR, Claus ED, Aharoni E et al (2014a) A large scale (N=102) functional neuroimaging study of error processing in a Go\/NoGo task. Behav Brain Res 268:127\u2013138","journal-title":"Behav Brain Res"},{"key":"7071_CR61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.bbr.2014.04.001","volume":"268","author":"VR Steele","year":"2014","unstructured":"Steele VR, Claus ED, Aharoni E et al (2014b) A large scale (N= 102) functional neuroimaging study of error processing in a Go\/NoGo task. Behav Brain Res 268:127\u2013138","journal-title":"Behav Brain Res"},{"issue":"1","key":"7071_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1521-0391.2009.00003.x","volume":"19","author":"LE Sullivan","year":"2010","unstructured":"Sullivan LE, Moore BA, O\u2019Connor PG et al (2010) The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine\/naloxone for the treatment of opioid dependence. Am J Addict 19(1):53\u201358","journal-title":"Am J Addict"},{"issue":"7","key":"7071_CR49","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.biopsych.2013.01.035","volume":"74","author":"MT Sutherland","year":"2013","unstructured":"Sutherland MT, Carroll AJ, Salmeron BJ, Ross TJ, Hong LE, Stein EA (2013) Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers. Biol Psychiatry 74(7):538\u2013546","journal-title":"Biol Psychiatry"},{"issue":"2","key":"7071_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/10550887.2024.2331522","volume":"43","author":"J van Amsterdam","year":"2025","unstructured":"van Amsterdam J, van den Brink W (2025) Explaining the high mortality among opioid-cocaine co-users compared to opioid-only users. A systematic review. J Addict Dis 43(2):121\u201331","journal-title":"J Addict Dis"},{"key":"7071_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuroscience.2024.05.005","volume":"549","author":"Z Wang","year":"2024","unstructured":"Wang Z, Hu Q, Tian C et al (2024) Prophylactic effects of n-acethylcysteine on inflammation-induced depression-like behaviors in mice. Neuroscience 549:42\u201354","journal-title":"Neuroscience"},{"issue":"6","key":"7071_CR59","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1037\/0022-3514.54.6.1063","volume":"54","author":"D Watson","year":"1988","unstructured":"Watson D, Clark LA, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54(6):1063","journal-title":"J Pers Soc Psychol"},{"issue":"7","key":"7071_CR58","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1176\/appi.ajp.160.7.1320","volume":"160","author":"RD Weiss","year":"2003","unstructured":"Weiss RD, Griffin ML, Mazurick C et al (2003) The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. Am J Psychiatry 160(7):1320\u20135","journal-title":"Am J Psychiatry"},{"issue":"4","key":"7071_CR55","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1176\/appi.ajp.2015.15060710","volume":"173","author":"CE Wilcox","year":"2016","unstructured":"Wilcox CE, Pommy JM, Adinoff B (2016) Neural circuitry of impaired emotion regulation in substance use disorders. Am J Psychiatry 173(4):344\u2013361","journal-title":"Am J Psychiatry"},{"issue":"3","key":"7071_CR11","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.drugalcdep.2005.08.010","volume":"81","author":"A Williamson","year":"2006","unstructured":"Williamson A, Darke S, Ross J, Teesson M (2006) The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence. Drug Alcohol Depend 81(3):293\u2013300","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"7071_CR62","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1038\/npp.2015.332","volume":"41","author":"PD Worhunsky","year":"2016","unstructured":"Worhunsky PD, Dager AD, Meda SA et al (2016) A preliminary prospective study of an escalation in \u201cMaximum Daily Drinks\u201d, fronto-parietal circuitry and impulsivity-related domains in young adult drinkers. Neuropsychopharmacology 41(6):1637\u20131647","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"7071_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41401-021-00661-0","volume":"43","author":"PF Wu","year":"2022","unstructured":"Wu PF, Guan XL, Wang F, Chen JG (2022) N-acetylcysteine facilitates extinction of cued fear memory in rats via reestablishing basolateral amygdala glutathione homeostasis. Acta Pharmacol Sin 43(2):260\u2013272","journal-title":"Acta Pharmacol Sin"},{"key":"7071_CR71","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.drugalcdep.2016.07.006","volume":"166","author":"SW Yip","year":"2016","unstructured":"Yip SW, DeVito EE, Kober H, Worhunsky PD, Carroll KM, Potenza MN (2016) Anticipatory reward processing among cocaine-dependent individuals with and without concurrent methadone-maintenance treatment: Relationship to treatment response. Drug Alcohol Depend 166:134\u2013142","journal-title":"Drug Alcohol Depend"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07071-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-026-07071-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-026-07071-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T02:02:11Z","timestamp":1778464931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-026-07071-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":75,"alternative-id":["7071"],"URL":"https:\/\/doi.org\/10.1007\/s00213-026-07071-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the University\u2019s Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All participants provided informed consent prior to participating.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors have read and approved the final version of the manuscript and consent to publish.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors report no conflicts of interest. Dr. Yip has consulted for Boehringer Ingelheim and sits on the Board of the APT Foundation. Dr. Potenza discloses the following. Dr. Potenza has consulted for Boehringer Ingelheim and Baria-Tek; has been involved in a patent application with Yale University and Novartis; has received research support (to Yale) from Mohegan Sun Casino and the Connecticut Council on Problem Gambling; has participated in surveys, mailings, or telephone consultations related to internet use, addictions, impulse-control disorders or other health topics; has consulted for and\/or advised gambling, non-profit, healthcare and legal entities on issues related to impulse control, internet use and addictive disorders; has performed grant reviews for research funding agencies; has edited journals and journal sections; has given academic lectures in grand rounds, CME events, and other clinical or scientific venues; and has generated books or book chapters for publishers of mental health texts.\u00a0","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work the authors used ChatGPT to improve readability and language. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement"}}]}}